Click to access HC_IssueBrief-PhysicianPressurePoints_TL_0316v2.pdf
Commenting on the Supreme Court’s decision, Jessica L. Ellsworth, partner at Hogan Lovells, says the limitations demonstrated that the high court “fully understood that the False Claims Act remains about fraudulent conduct — not garden variety foot-faults that a regulated party may experience in complying with complex regulatory and statutory obligations.”
Why an obscure Supreme Court case is a big deal for prescription drugs

“Consumers and the health system as a whole benefit from a more competitive prescription drug market,” Marilyn Tavenner, president and CEO of America’s Health Insurance Plans, said in a statement. “Protecting monopoly-like pricing schemes threaten[s] consumers’ access to more affordable prescription medications.”


https://www.propublica.org/article/a-blow-to-health-care-transparency?
The U.S. Supreme Court ruled that states cannot require many large employers to submit health care claims to a massive database. Here’s why that matters.